Komori
Business Alliances3624AXEL MARK INC.Information and Communications, Services and Others

Notice Regarding the Business Alliance with Medical Corporation Medical Frontier (TCB Group)

AXEL MARK INC. has entered into a business alliance with 医療法人社団メディカルフロンティア covering the joint development and sale of cosmetics and marketing support using advertising data. The alliance does not involve any transfer of capital or acquisition of shares.

Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Agreements reached under this partnership

Business Alliances
3624AXEL MARK INC.
Alliance partner医療法人社団メディカルフロンティア
Details of the alliance
  1. 1

    Sale and joint development of cosmetics

  2. 2

    Marketing support using expertise in data-driven DSPs and advertising distribution networks

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

Numerical targets under the alliance

Aiming to achieve a market capitalization of ¥20 billion (a medium-term target; no specific timeframe for achievement is stated)

About the partner
Business DescriptionProvision of aesthetic medicine services, including cosmetic surgery and cosmetic dermatology, and operation of businesses including “TCB 東京中央美容外科”
LocationFukushima, Fukushima Prefecture
Share capitalThere is no stated capital or equity interest.
Net SalesApproximately ¥100 billion (the TCB Group's total sales scale; the fiscal year-end is not stated)
Impact on Business Performance

The impact on consolidated full-year results for the fiscal year ending September 2026 is currently under review. However, the Company expects the measures to contribute to improved performance over the medium to long term as they progress.

Date of board resolution23 July 2026Contract Date23 July 2026Alliance start date23 July 2026
Agreements reached under this partnership
ItemDetails
Name of alliance partner医療法人社団メディカルフロンティア
Alliance partner's business activitiesProvision of aesthetic medicine services, including cosmetic surgery and cosmetic dermatology, and operation of businesses including “TCB 東京中央美容外科”
Alliance partner's locationFukushima, Fukushima Prefecture
Alliance partner's capitalThere is no stated capital or equity interest.
Alliance partner's net salesApproximately ¥100 billion (the TCB Group's total sales scale; the fiscal year-end is not stated)
Type of allianceBusiness Alliances
Details of the allianceSale and joint development of cosmetics, Marketing support using expertise in data-driven DSPs and advertising distribution networks
Numerical targets under the allianceAiming to achieve a market capitalization of ¥20 billion (a medium-term target; no specific timeframe for achievement is stated)
Date of board resolution23 July 2026
Contract Date23 July 2026
Alliance start date23 July 2026
Impact on Business PerformanceThe impact on consolidated full-year results for the fiscal year ending September 2026 is currently under review. However, the Company expects the measures to contribute to improved performance over the medium to long term as they progress.
Items this document does not state (11)
Alliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodShareholding PolicyShare Acquisition Date and Payment DateChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To mutually leverage 医療法人社団メディカルフロンティア's customer base and expertise in aesthetic medicine, together with the Company's expertise in cosmetics planning, development and e-commerce sales, as well as its knowledge of DSPs and advertising distribution networks, with the aim of expanding the beauty and wellness business and aesthetic medicine-related business and improving their profitability.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Business Alliance with Medical Corporation Medical Frontier (TCB Group) | AXEL MARK INC. (3624) timely disclosure | Komori